Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From MASH to HCC: the role of Gas6/TAM receptors.
Apostolo D, Ferreira LL, Vincenzi F, Vercellino N, Minisini R, Latini F, Ferrari B, Burlone ME, Pirisi M, Bellan M. Apostolo D, et al. Among authors: vercellino n. Front Immunol. 2024 Jan 17;15:1332818. doi: 10.3389/fimmu.2024.1332818. eCollection 2024. Front Immunol. 2024. PMID: 38298195 Free PMC article. Review.
Outpatient surgery at the Pediatric Dermatology Unit.
Herzum A, Occella C, Pastorino C, Gariazzo L, Vercellino N, Vellone VG, Ferro J, Viglizzo G. Herzum A, et al. Among authors: vercellino n. Ital J Dermatol Venerol. 2023 Dec;158(6):498-499. doi: 10.23736/S2784-8671.23.07688-0. Epub 2023 Sep 26. Ital J Dermatol Venerol. 2023. PMID: 37750846 No abstract available.
Clinical and genetic analysis of patients with segmental overgrowth features and somatic mammalian target of rapamycin (mTOR) pathway disruption: Possible novel clinical issues.
Romano F, Madia F, De Marco P, Ognibene M, Guerrisi S, Scala M, Iacomino M, Baldassari S, Vercellino N, Manunza F, Tallone R, Pavanello M, Piatelli G, Garaventa A, Zara F, Capra V. Romano F, et al. Among authors: vercellino n. Birth Defects Res. 2022 Dec 1;114(20):1440-1448. doi: 10.1002/bdr2.2113. Epub 2022 Nov 8. Birth Defects Res. 2022. PMID: 36345927
Sequelae following infantile haemangiomas treated with propranolol.
Baselga E, El Hachem M, Diociaiuti A, Carnevale C, Downey C, Roe E, Mascaro P, Neri I, Leuzzi M, Bernabeu-Wittel J, Monserrat-García MT, Ortiz-Prieto A, Torrelo A, Knopfel N, Vercellino N, Manunza F, Oranges T, Bassi A, Gonzalez-Enseñat MA, Vicente A, Gich I, Puig L. Baselga E, et al. Among authors: vercellino n. Eur J Dermatol. 2021 Dec 1;31(6):785-790. doi: 10.1684/ejd.2021.4172. Eur J Dermatol. 2021. PMID: 35107070
Safety and effectiveness of oral propranolol for infantile hemangiomas started before 5 weeks and after 5 months of age: an Italian multicenter experience.
El Hachem M, Gesualdo F, Diociaiuti A, Berti I, Vercellino N, Boccaletti V, Neri I, Porcedda G, Greco A, Carnevale C, Oranges T, Cutrone M, Dalmonte P. El Hachem M, et al. Among authors: vercellino n. Ital J Pediatr. 2017 Apr 19;43(1):40. doi: 10.1186/s13052-017-0357-9. Ital J Pediatr. 2017. PMID: 28424095 Free PMC article.
Sixteen years of experience with persistent chylothorax in children.
Pini Prato A, Bava GL, Dalmonte P, Vercellino N, Michelazzi A, Pio L, Avanzini S, Mattioli G. Pini Prato A, et al. Among authors: vercellino n. Minerva Pediatr. 2017 Dec;69(6):476-480. doi: 10.23736/S0026-4946.16.04324-3. Epub 2015 Dec 17. Minerva Pediatr. 2017. PMID: 26677950
19 results